COMMUNIQUÉS West-GlobeNewswire
 
      -   
  Biomerica Announces Third Quarter Financial Results17/04/2018
-   
  Maple Leaf Green World Inc. Receives Final Approval to List on the NEO Exchange and Delist Common Shares from the TSXV17/04/2018
-   
  Sarah Boyce Joins Akcea Therapeutics as President and Member of the Board of Directors17/04/2018
-   
  Akcea and Ionis Complete Licensing Transaction to Commercialize Inotersen for hATTR17/04/2018
-   
  NSS Labs Announces 2018 Advanced Endpoint Protection Group Test Results17/04/2018
-   
  Oncobiologics Appoints Randy Thurman to Board of Directors17/04/2018
-   
  Cyclacel’s CYC065 CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic Lymphocytic Leukemia17/04/2018
-   
  Resverlogix Announces Proposed Offering of Units17/04/2018
-   
  Hemispherx Successfully Completes Production of More Than 8,500 Vials of Ampligen for Commercial Sales and Expanded Clinical Programs17/04/2018
-   
  HMS Holdings Corp. To Report First Quarter 2018 Financial and Operating Results17/04/2018
-   
  Agritek Holdings Inc. Applauds New Deal With President Trump And Senator Cory Gardner Clearing Way For Colorado Medical And Recreational Cannabis Laws Including New Agritek Operations17/04/2018
-   
  Cesca Therapeutics Announces First Evaluation Agreement With a Leading U.S. Academic Research Institution for X-Series™ Products That Provide Automated, Closed System Cellular Processing17/04/2018
-   
  Scythian Biosciences Appoints Gabriel Meneses as Vice President of Latin America and Caribbean17/04/2018
-   
  Oxford Immunotec Schedules First Quarter 2018 Earnings Release and Conference Call for May 1, 201817/04/2018
-   
  Extendicare Completes $110 million Offering of 5.00% Convertible Debentures17/04/2018
-   
  GTX Corp SmartSoles Showcased at the Innovation & Style 2018 Fair in Munich17/04/2018
-   
  Wave Life Sciences to Present Data on ALS and FTD Programs and on Huntington's Disease at the 2018 American Academy of Neurology Annual Meeting17/04/2018
-   
  VBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients17/04/2018
-   
  Novaseek Research and CoxHealth Launch Partnership to Advance Biomedical and Clinical Research17/04/2018
Pages